Clinical Trials Browser

Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) × Clear all

NCT07058519 2025-11-26

A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC

Phase 2 Recruiting

Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)